Description
Noramco is a global leader in the production of controlled substances and active pharmaceutical ingredients (APIs) for the pharmaceutical industry.
Headquartered in Delaware, USA, Noramco specialises in the development and manufacture of controlled substance APIs, focusing on opioids, cannabinoids, and stimulants. With decades of experience, the company ensures high-quality, compliant manufacturing, offering tailored solutions for pharmaceutical companies. Their expertise extends to synthetic and semi-synthetic compounds.
Key Products and Services
- Controlled Substance APIs
- Opioid APIs
- Cannabinoid APIs
- Stimulant APIs
Noramco remains dedicated to innovation and regulatory excellence, supporting global pharmaceutical advancements.
Contact Information
Related Listings

CDMO Live Americas . October 20-21, Boston 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st Oct 2026

AI + Digital Maturity in Contract Manufacturing 2026
Exclusive research roundtable on Day Zero of CDMO Live Americas 2026, in partnership with MasterControl











